Detalles de la búsqueda
1.
Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.
BMC Infect Dis
; 13: 190, 2013 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23621902
2.
Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study.
Rheumatol Ther
; 10(5): 1241-1253, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37453020
3.
DREAMM-2: Indirect Comparisons of Belantamab Mafodotin vs. Selinexor + Dexamethasone and Standard of Care Treatments in Relapsed/Refractory Multiple Myeloma.
Adv Ther
; 38(11): 5501-5518, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34561812
4.
Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.
Eur J Pediatr
; 169(11): 1379-86, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20559656
5.
Pembrolizumab versus the standard of care for relapsed and refractory classical Hodgkin's lymphoma progressing after brentuximab vedotin: an indirect treatment comparison.
Expert Rev Hematol
; 11(6): 503-511, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29764245
6.
Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-effectiveness Analysis.
Clin Ther
; 37(7): 1529-40, 2015 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26031617
7.
Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary.
J Health Econ Outcomes Res
; 1(1): 62-82, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664146
8.
Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value.
Curr Med Res Opin
; 28(8): 1281-7, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22697277
9.
Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine.
Pediatr Infect Dis J
; 29(10): 957-63, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20442684
Resultados
1 -
9
de 9
1
Próxima >
>>